Cognition Therapeutics
NASDAQ: CGTX
$0.93
+0.03
(+3.80%)
as on
Cognition Therapeutics Stock Performance
as on October 5, 2026 at 2:15 pm IST
Day's Low
Day's High
$0.90$0.93
2.71%
Downside
0.53%
Upside
52 Week's Low
52 Week's High
$0.55$2.0540.54%
Downside
121.60%
Upside
Cognition Therapeutics share price movements today
- Previous Close
- $0.89
- Open
- $0.91
- Volume
- 397.4K
- Market Cap
- $88.0M
- Day's Low - High
- $0.90 - $0.93
- 52 Week Low - High
- $0.55 - $2.05
Cognition Therapeutics Historical Returns
- 1 Month Return
- -10.18 %
- 3 Month Return
- -20.93 %
- 1 Year Return
- -40.32 %
- 3 Year Return
- -29.92 %
- 5 Year Return
- 0 %
Cognition Therapeutics Stock Fundamentals & Key Indicators
Check Cognition Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$88.0M
EPS (TTM)
-0.192
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.82
Industry PE ratio
-3.02
PEG Ratio
-0.03
EBITDA
-16.6M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-50.17%
Cognition Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Cognition Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $88.0M | NA | -4.82 | 0.00% | 0.00% | |
| StrongBuy | $44.3B | 637.21% | -23.32 | 0.00% | 0.00% | |
| Neutral | $75.9B | -42.79% | -23.81 | -12.57% | 0.00% | |
| StrongBuy | $127.9B | 185.14% | 29.14 | 86.04% | 0.00% | |
| Buy | $75.7B | 33.45% | 17.55 | 84.86% | 0.50% |
Stock Returns calculator for Cognition Therapeutics Stock including INR - Dollar returns
The Cognition Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Cognition Therapeutics investment value today
Current value as on today
₹64,782
Returns
Returns from Cognition Therapeutics Stock
Dollar Impact
₹5,099 (+5.1%)
Analyst Recommendation on Cognition Therapeutics Stock
Based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Cognition Therapeutics. Average target price of $3.33
Cognition Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Cognition Therapeutics.
What analysts predicted
72.22%UPSIDE
Target Price
$3.33
Current Price
$0.9251
Analyzed by
1 Analysts
High
$3
Target
$3.33
Low
$3
Cognition Therapeutics target price $3.33, a slight upside of 72.22% compared to current price of $0.9251. According to 1 analysts rating.
Indian Investors' Interest in Cognition Therapeutics Stock
Search interest for Cognition Therapeutics Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Cognition Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Cognition Therapeutics Annual Profit & Loss
All numbers in Millions USD
Cognition Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Cognition Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Cognition Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 84.5% return, outperforming this stock by 114.4%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 607.2%
NEGATIVE IMPACTPrice Dip
In the last 3 months, CGTX stock has moved down by -20.9%
About Cognition Therapeutics
| Organisation | Cognition Therapeutics |
| Headquarters | 2500 Westchester Avenue, Purchase, NY, 10577, US |
| Industry | Biotechnology |
| CEO | Lisa Ricciardi |
Key Management of Cognition Therapeutics
Name | Title |
|---|---|
Ms. Lisa Ricciardi | CEO, President & Director |
Mr. John Brendan Doyle | Chief Financial Officer |
Dr. Anthony O. Caggiano M.D., Ph.D. | Chief Medical Officer |
Dr. Steven A. Weissman Ph.D. | VP & Head of CMC |
Ms. Anita Cornet | Head of Quality |
Mr. Bobby Horn | Corporate Controller |
FAQs
What is Cognition Therapeutics share price today?
Cognition Therapeutics share price today is $0.93 as on at the close of the market. Cognition Therapeutics share today touched a day high of $0.93 and a low of $0.90.
What is the 52 week high and 52 week low for Cognition Therapeutics share?
Cognition Therapeutics share touched a 52 week high of $2.05 on and a 52 week low of $0.55 on . Cognition Therapeutics stock price today i.e. is closed at $0.93,which is 54.87% down from its 52 week high and 68.17% up from its 52 week low.
What is Cognition Therapeutics's market capitalisation today?
Cognition Therapeutics market capitalisation is $0.00T as on .
How to invest in Cognition Therapeutics Stock (CGTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Cognition Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Cognition Therapeutics Stock (CGTX) from India?
Indian investors can start investing in Cognition Therapeutics (CGTX) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Cognition Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Cognition Therapeutics share’s latest price of $0.93 as on October 5, 2026 at 8:45 am IST, you will get 10.8096 shares of Cognition Therapeutics. Learn more about
fractional shares .